Genetic Epidemiology of HCV-related Liver Disease
HCV 相关肝病的遗传流行病学
基本信息
- 批准号:7514173
- 负责人:
- 金额:$ 15.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-15 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdvanced DevelopmentAlcohol abuseAlcohol consumptionAmericanAndrogen ReceptorAndrogensAwardBinding ProteinsBiologicalBiopsy SpecimenBloodCAG repeatCase-Control StudiesCentral obesityChronicCirrhosisCollectionDNADataDepositionDevelopmentDiabetes MellitusDigestive System DisordersElevationEnrollmentEnvironmentEnvironmental ExposureEnvironmental Risk FactorEpidemicEpidemiologic MethodsEvaluationExposure toFatty LiverFatty acid glycerol estersFibrosisFoundationsFutureGastroenterologyGenderGene ExpressionGenesGeneticGenetic PolymorphismGenetic VariationGenotypeGoalsGonadal Steroid HormonesHealthHepatitis BHepatitis CHepatitis C virusHormone ReceptorHydroxysteroid DehydrogenasesIndividualInfectionInflammationInjuryInsulin ResistanceInsulin Resistance PathwayJointsLeptinLeukocytesLinkLiverLiver FibrosisLiver diseasesMeasuresMediatingMedical centerMentorsMessenger RNAMetabolic PathwayMethodsMolecular EpidemiologyMolecular GeneticsNecrosisNewly DiagnosedNumbersObesityOutcomePathogenesisPathologistPathway interactionsPatientsPeripheralPeroxisome Proliferator-Activated ReceptorsPlayPolycystic Ovary SyndromePredispositionPrimary Health CarePrimary carcinoma of the liver cellsPrincipal InvestigatorRNAReceptor GeneRegulatory ElementRelative RisksResearchResearch PersonnelRiskRisk FactorsRoleSamplingScoreSerologicalSeveritiesSpecimenStandards of Weights and MeasuresSteatohepatitisSterolsSusceptibility GeneTestingTestosteroneTexasTrainingVariantVeteransWomanWorkabdominal fatadiponectinbasecohortendophenotypegene environment interactiongene interactiongenetic associationgenetic epidemiologyliver biopsymalemembermenmicrosomal triglyceride transfer proteinnoveloncologyperipheral bloodprogramsprospectivereceptorresponseskills
项目摘要
DESCRIPTION (provided by applicant):
An estimated 20-30% of the four million Americans with hepatitis C infection (HCV) are projected to develop advanced fibrosis and cirrhosis after 2-3 decades of infection. Differences in exposure to fibrosis-promoting risk factors like alcohol abuse likely explain some of this difference in fibrosis risk. However, current research suggests that genetic factors may also influence the risk of advanced fibrosis in HCV patients. Two factors that research has repeatedly shown to be associated with development of advanced liver disease are male gender and abdominal obesity. However, the specific role genetic factors, including those related to male sex hormone receptor or androgen receptors (AR) and to insulin resistance (IR) associated with abdominal obesity, may play in fibrosis risk remains unclear. The goal of the proposed study is to ascertain the role that changes in AR and IR genes play in increasing risk of advanced fibrosis. The associated specific aims are: 1) to identify and collect data on a large and representative cohort of male veterans with HCV infection; 2) to test the hypothesis that 'high risk" variants of genes related to IR either alone or in conjunction with abdominal obesity increase fibrosis risk; and 3) to test the hypothesis that 'high risk' variants of genes related to AR also increase fibrosis risk. Aim 1 will be accomplished with standard epidemiology methods for cohort identification and will be performed at the Michael E. DeBakey VA. Aims 2 and 3 will be addressed through a case-control study in which cohort members with advanced fibrosis (cases) are compared to those with mild fibrosis (controls). The research plan, didactic training and outstanding mentoring environment will work together to allow the principal investigator to acquire new skills as well as refine existing skills in the development and execution of novel genetic epidemiology studies, allowing her to develop into an independent investigator in genetic epidemiology of chronic liver and digestive disorders.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Donna Lorraine White其他文献
Donna Lorraine White的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Donna Lorraine White', 18)}}的其他基金
Sex hormones and HCV-related liver disease progression
性激素和 HCV 相关肝病进展
- 批准号:
9979785 - 财政年份:2017
- 资助金额:
$ 15.79万 - 项目类别:
Androgen Receptor Pathway and Risk of Hepatic Fibrosis in Hepatitis C
丙型肝炎中雄激素受体途径和肝纤维化风险
- 批准号:
8446061 - 财政年份:2013
- 资助金额:
$ 15.79万 - 项目类别:
Androgen Receptor Pathway and Risk of Hepatic Fibrosis in Hepatitis C
丙型肝炎中雄激素受体途径和肝纤维化风险
- 批准号:
8653960 - 财政年份:2013
- 资助金额:
$ 15.79万 - 项目类别:
Genetic Epidemiology of HCV-related Liver Disease
HCV 相关肝病的遗传流行病学
- 批准号:
7928376 - 财政年份:2008
- 资助金额:
$ 15.79万 - 项目类别:
Genetic Epidemiology of HCV-related Liver Disease
HCV 相关肝病的遗传流行病学
- 批准号:
8128652 - 财政年份:2008
- 资助金额:
$ 15.79万 - 项目类别:
Genetic Epidemiology of HCV-related Liver Disease
HCV 相关肝病的遗传流行病学
- 批准号:
7686059 - 财政年份:2008
- 资助金额:
$ 15.79万 - 项目类别:
Genetic Epidemiology of HCV-related Liver Disease
HCV 相关肝病的遗传流行病学
- 批准号:
8319548 - 财政年份:2008
- 资助金额:
$ 15.79万 - 项目类别:
Genetic Epidemiology of HCV-related Liver Disease
HCV 相关肝病的遗传流行病学
- 批准号:
7918135 - 财政年份:2008
- 资助金额:
$ 15.79万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 15.79万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 15.79万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 15.79万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 15.79万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 15.79万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 15.79万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 15.79万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 15.79万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 15.79万 - 项目类别: